• Explore /
  • Poster
  • / Atezolizumab (atezo) therapy for locally advanced/metastatic urinary tract carcinoma (mUTC) in patients (pts) with poor performance status (PS): Analysis of the prospective global SAUL study.

Atezolizumab (atezo) therapy for locally advanced/metastatic urinary tract carcinoma (mUTC) in patients (pts) with poor performance status (PS): Analysis of the prospective global SAUL study.

Abstract Video & Slides Poster

Authors

Daniel Castellano

Daniel Castellano

Hospital Universitario 12 de Octubre, Madrid, Spain

Daniel Castellano , Craig Gedye , Giuseppe Fornarini , Andre P. Fay , Jens Voortman , Michal Mego , Aristotelis Bamias , Jason Francis Lester , Robert A Huddart , Michaela Matouskova , Howard Gurney , Begona Mellado , Michael Ong , Filipa Carneiro , Florian Seseke , Laura Milesi , Shahrokh F. Shariat , Simon Fear , Sabine de Ducla , Cora N. Sternberg

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2020 ASCO Virtual Scientific Program

Session Type

Poster Session

Session Title

Genitourinary Cancer—Kidney and Bladder

Track

Genitourinary Cancer—Kidney and Bladder

Sub Track

Bladder Cancer

Clinical Trial Registration Number

NCT02928406

Citation

J Clin Oncol 38: 2020 (suppl; abstr 5035)

DOI

10.1200/JCO.2020.38.15_suppl.5035

Abstract #

5035

Poster Bd #

104

Abstract Disclosures

Similar Posters

First Author: Cora N. Sternberg

First Author: Kazuomi Ueshima

First Author: Jens Bedke

First Author: Toshiharu Hirose